Loss of chromosome 1p/19q in oligodendroglial tumors: Refinement of chromosomal critical regions and evaluation of internexin immunostaining as a surrogate marker

Journal of Neuropathology and Experimental Neurology

Volumn 70, Issue 3, 2011, Pages 177-182

  Buckley, Patrick G ^a,b   Alcock, Leah ^a,b   Heffernan, Josephine ^c   Woods, Jack ^c   Brett, Francesca ^c   Stallings, Raymond L ^a,b   Farrell, Michael A ^c  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^c BEAUMONT HOSPITAL   (Ireland)

Author keywords

aCGH; Deletion; Internexin; Oligodendroglioma; Prognosis

Indexed keywords

ALPHA INTERNEXIN;

ARTICLE; CHROMOSOME 10; CHROMOSOME 16; CHROMOSOME 17; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME ABERRATION; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; OLIGODENDROGLIOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; COMPARATIVE GENOMIC HYBRIDIZATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERMEDIATE FILAMENT PROTEINS; OLIGODENDROGLIOMA;

EID: 79952041071     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31820c765b     Document Type: Article

References (27)

1. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumors of the central nervous system. Acta Neuropathol 2007;114:97-109 (Pubitemid 47103521)
2. Perry A, Burton SS, Fuller GN, et al. Oligodendroglial neoplasms with ganglioglioma-like maturation: A diagnostic pitfall. Acta Neuropathol 2010;120:237-52
3. Gonzales M, Dale S, Susman M, et al. Dysembryoplastic neuroepithelial tumor (DNT)-like oligodendrogliomas or DNTs evolving into oligodendrogliomas: Two illustrative cases. Neuropathology 2007;27:324-30 (Pubitemid 47063278)
4. Phillips HS, Kharbanda S, Chen R, et al. Molecular subclasses of highgrade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006;9:157-73 (Pubitemid 43357943)
5. Cooper LA, Gutman DA, Long Q, et al. The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas. PLoS One 2010;5:e12548
6. Jenkins RB, Blair H, Ballman KV, et al. A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 2006;66:9852-61 (Pubitemid 44672036)
7. Smith JS, Perry A, Borell TJ, et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 2000;18:636-45 (Pubitemid 30078545)
8. Idbaih A, Marie Y, Pierron G, et al. Two types of chromosome 1p losses with opposite significance in gliomas. Ann Neurol 2005;58:483-87 (Pubitemid 41266639)
9. Idbaih A, Marie Y, Lucchesi C, et al. BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas. Int J Cancer 2008;122:1778-86 (Pubitemid 351413424)
10. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998;90:1473-79 (Pubitemid 28482012)
11. Ducray F, Idbaih A, de Reynies A, et al. Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile. Mol Cancer 2008;7:41
12. Mukasa A, Ueki K, Ge X, et al. Selective expression of a subset of neuronal genes in oligodendroglioma with chromosome 1p loss. Brain Pathol 2004;14:34-42 (Pubitemid 38200587)
13. Ducray F, Criniere E, Idbaih A, et al. alpha-Internexin expression identifies 1p19q codeleted gliomas. Neurology 2009;72:156-61
14. Lariviere RC, Julien JP. Functions of intermediate filaments in neuronal development and disease. J Neurobiol 2004;58:131-48 (Pubitemid 37543344)
15. Paris PL, Albertson DG, Alers JC, et al. High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays. Am J Pathol 2003;162:763-70 (Pubitemid 36237485)
16. Devries S, Nyante S, Korkola J, et al. Array-based comparative genomic hybridization from formalin-fixed, paraffin-embedded breast tumors. J Mol Diagn 2005;7:65-71 (Pubitemid 40310167)
17. Lassmann S, Weis R, Makowiec F, et al. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas. J Mol Med 2007;85:293-304
18. Giannini C, Burger PC, Berkey BA, et al. Anaplastic oligodendroglial tumors: Refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402. Brain Pathol 2008;18:360-69 (Pubitemid 351782844)
19. Kouwenhoven MC, Gorlia T, Kros JM, et al. Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951. Neuro Oncol 2009;11:737-46
20. Selzer RR, Richmond TA, Pofahl NJ, et al. Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using finetiling oligonucleotide array CGH. Genes Chromosomes Cancer 2005;44:305-19 (Pubitemid 41397100)
21. Workman C, Jensen LJ, Jarmer H, et al. A new non-linear normalization method for reducing variability in DNA microarray experiments. Genome Biol 2002;3:research0048
22. Snuderl M, Eichler AF, Ligon KL, et al. Polysomy for chromosomes 1 and 19 predicts earlier recurrence in anaplastic oligodendrogliomas with concurrent 1p/19q loss. Clin Cancer Res 2009;15:6430-37
23. Lennon PA, Zhuang Y, Pierson D, et al. Bacterial artificial chromosome array-based comparative genomic hybridization using paired formalin-fixed, paraffin-embedded and fresh frozen tissue specimens in multiple myeloma. Cancer 2009;115:345-54
24. Ching GY, Liem RK. RE1 silencing transcription factor is involved in regulating neuron-specific expression of alpha-internexin and neurofilament genes. J Neurochem 2009;109:1610-23
25. Blom T, Tynninen O, Puputti M, et al. Molecular genetic analysis of the REST/NRSF gene in nervous system tumors. Acta Neuropathol 2006;112:483-90 (Pubitemid 44469168)
26. Lauren J, Airaksinen MS, Saarma M, et al. A novel gene family encoding leucine-rich repeat transmembrane proteins differentially expressed in the nervous system. Genomics 2003;81:411-21 (Pubitemid 36379163)
27. Linhoff MW, Lauren J, Cassidy RM, et al. An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizers. Neuron 2009;61:734-49